The objective of this study was to compare the efficacy and safety of DA-α injection versus EPO for treating renal anemia amongst Indian patients with end-stage renal disease (ESRD) undergoing dialysis. The gene discussed is EPO; the disease is stage 5 chronic kidney disease.